Twitxy Saved

Ty Miller Lab

Verified account This account is verified. Learn more

@TyMillerLab

tymillerlab.org @CWRUSOM @UHhospitals | Researchers of #braincancer, myeloid cells, epigenetics, #immunotherapy |
Dedicated to finding cures for patients
Cleveland, OH tymillerlab.org Joined July 2012
538 Following 1.8K Followers 2.1K Posts

Latest posts 5

Pinned post

Ty Miller Lab Verified account @TyMillerLab
Congrats to @brycelmash for winning a best poster award amongst ~1000 posters at #SNO2026! A great collaborative project with our lab and @kadochlab at @DanaFarber

Thanks @FilbinMariella and @NeuroOnc for highlighting Bryce's work!

@caseccc @cwrumstp
@CKadoch
SNO @NeuroOnc 4d
The #SNO2026 Poster and Networking Session last night. Researchers shared their latest discoveries, connected with colleagues, and sparked new collaborations across the neuro-oncology community. #SNO2026 #ScientificMeeting
View quoted post on X
4 replies 1 reposts 27 likes 1.7K views View on X
Ty Miller Lab Verified account @TyMillerLab
Official Miller Family team picture for @bikeVeloSano 2026! Ready to ride this morning to raise funds for cancer research at the Case Comprehensive Cancer Center!
@caseccc

#velosano 100% for the Cure

If you are able to support:
Tyler: give.velosano.org/TyMillerFam
Brittany: give.velosano.org/BrittanyM
Skyler: give.velosano.org/skylermiller
Zander: give.velosano.org/Z-Miller

@CWRUSOM
0 replies 1 reposts 21 likes 745 views View on X
Ty Miller Lab Verified account @TyMillerLab
Why has immunotherapy been so hard in glioblastoma?

A major reason is the immune microenvironment.

In this open-access review, we summarize how single-cell genomics is changing our understanding of glioma immune biology — and why we need to think beyond cell types.
academic.oup.com/noa/article/8/…
academic.oup.com Redefining the immune microenvironment of gliomas in the era of single-cell genomics Abstract. Infiltrating gliomas are the most common primary malignant brain tumor and remain universally fatal. Over the past decade, advances in single-cel